Aravind Sanjeevaiah

736 total citations
31 papers, 559 citations indexed

About

Aravind Sanjeevaiah is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aravind Sanjeevaiah has authored 31 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Aravind Sanjeevaiah's work include Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Aravind Sanjeevaiah is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Aravind Sanjeevaiah collaborates with scholars based in United States and Spain. Aravind Sanjeevaiah's co-authors include Brian H. Johnstone, Keith L. March, Stephanie Merfeld‐Clauss, Michael P. Murphy, Dmitry O. Traktuev, M. Reza Saadatzadeh, Daniel N. Prater, David A. Ingram, Muhammad Shaalan Beg and Matthew R. Porembka and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Radiology.

In The Last Decade

Aravind Sanjeevaiah

30 papers receiving 550 citations

Peers

Aravind Sanjeevaiah
Kai Jaquet Germany
M. Walraven Netherlands
Cheen P. Khoo United Kingdom
Hyun Jung Moon South Korea
Arash Rezazadeh United States
Aravind Sanjeevaiah
Citations per year, relative to Aravind Sanjeevaiah Aravind Sanjeevaiah (= 1×) peers Audrey Cras

Countries citing papers authored by Aravind Sanjeevaiah

Since Specialization
Citations

This map shows the geographic impact of Aravind Sanjeevaiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aravind Sanjeevaiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aravind Sanjeevaiah more than expected).

Fields of papers citing papers by Aravind Sanjeevaiah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aravind Sanjeevaiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aravind Sanjeevaiah. The network helps show where Aravind Sanjeevaiah may publish in the future.

Co-authorship network of co-authors of Aravind Sanjeevaiah

This figure shows the co-authorship network connecting the top 25 collaborators of Aravind Sanjeevaiah. A scholar is included among the top collaborators of Aravind Sanjeevaiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aravind Sanjeevaiah. Aravind Sanjeevaiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanford, Nina N., Radhika Kainthla, David Hsiehchen, et al.. (2023). Characteristics and clinical outcomes in young‐onset cholangiocarcinoma. Cancer Medicine. 12(13). 14094–14103. 10 indexed citations
2.
Karalis, John D., Tarek Sawas, Nina N. Sanford, et al.. (2023). Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites. Journal of Surgical Oncology. 129(4). 718–727. 3 indexed citations
3.
Ahn, Chul, Nina N. Sanford, Georgios Karagkounis, et al.. (2022). Trends in Adjuvant Chemotherapy Use Among Stage III Colon Cancer in Non-Elderly and Low Comorbidity Patients. Clinical Colorectal Cancer. 21(4). 315–324. 2 indexed citations
4.
5.
Beg, Muhammad Shaalan, Nina N. Sanford, Aravind Sanjeevaiah, et al.. (2021). Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital. JCO Oncology Practice. 17(5). e614–e622. 3 indexed citations
7.
Özer, Muhammet, Muhammad Shaalan Beg, Nina N. Sanford, et al.. (2020). Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors. Cancers. 12(10). 2990–2990. 5 indexed citations
8.
Özer, Muhammet, Syed Mohammad Ali Kazmi, Nina N. Sanford, et al.. (2020). Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor. Cancers. 12(9). 2501–2501. 7 indexed citations
9.
Sanjeevaiah, Aravind, Rama Suresh, Rutika Mehta, et al.. (2020). P-131 Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial. Annals of Oncology. 31. S132–S132. 1 indexed citations
10.
Sanjeevaiah, Aravind, et al.. (2020). Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches. Cancers. 12(3). 592–592. 5 indexed citations
11.
Beg, Muhammad Shaalan, Hao Zhu, David Hsieh, et al.. (2020). A phase II clinical trial of the phosphatidylserine targeting antibody, bavituximab, in combination with pembrolizumab in patients with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 38(4_suppl). TPS599–TPS599. 1 indexed citations
12.
Sanford, Nina N., Michael R. Folkert, Todd A. Aguilera, et al.. (2020). Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016. American Journal of Clinical Oncology. 43(12). 850–856. 4 indexed citations
13.
Sanford, Nina N., Todd A. Aguilera, Muhammad Shaalan Beg, et al.. (2020). Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015. American Journal of Clinical Oncology. 43(5). 311–318. 5 indexed citations
14.
Kazmi, Syed Mohammad Ali, Nina N. Sanford, Todd A. Aguilera, et al.. (2020). Distinct clinical characteristics of young-onset pancreatic cancer patients.. Journal of Clinical Oncology. 38(4_suppl). 674–674. 1 indexed citations
15.
Kalva, Sanjeeva P., et al.. (2019). Liquid Biopsy for Cancer: Review and Implications for the Radiologist. Radiology. 294(1). 5–17. 63 indexed citations
16.
Park, Haeseong, Nikolaos A. Trikalinos, Aravind Sanjeevaiah, et al.. (2019). Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma.. Journal of Clinical Oncology. 37(15_suppl). TPS4150–TPS4150. 1 indexed citations
17.
Sanjeevaiah, Aravind, Thomas A. Kerr, & Muhammad Shaalan Beg. (2018). Approach and management of checkpoint inhibitor-related immune hepatitis. Journal of Gastrointestinal Oncology. 9(1). 220–224. 24 indexed citations
18.
Sanjeevaiah, Aravind, Naga Cheedella, Caitlin A. Hester, & Matthew R. Porembka. (2018). Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications. Journal of Oncology Practice. 14(4). 217–224. 49 indexed citations
19.
Gangaraju, Rajashekhar, Malgorzata M. Kamocka, Mark A. Suckow, et al.. (2010). Pro‐inflammatory angiogenesis is mediated by p38 MAP kinase. Journal of Cellular Physiology. 226(3). 800–808. 42 indexed citations
20.
Sanjeevaiah, Aravind, et al.. (2007). Precocious Puberty and Large Multicystic Ovaries in Young Girls with Primary Hypothyroidism. Endocrine Practice. 13(6). 652–655. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026